DYNE THERAPEUTICS INC

Ticker: DYN CUSIP: 26818M108 Class: Common Stock

Atlas Venture Life Science Advisors, LLC's Holding History (CIK: 0001917529)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 9,130,465 Value ($000) $178,592 Avg Close $18.94 Range $12.33 - $25.00
Q3 2025
Shares 9,130,465 Value ($000) $115,500 Avg Close $11.41 Range $8.06 - $14.35
Q2 2025
Shares 9,130,465 Value ($000) $86,922 Avg Close $11.01 Range $6.36 - $15.23
Q1 2025
Shares 9,130,465 Value ($000) $95,505 Avg Close $14.30 Range $9.96 - $26.22
Q4 2024
Shares 8,019,354 Value ($000) $188,936 Avg Close $29.58 Range $23.05 - $35.90
Q3 2024
Shares 8,020,136 Value ($000) $288,083 Avg Close $39.80 Range $23.55 - $47.45
Q2 2024
Shares 8,020,136 Value ($000) $283,031 Avg Close $29.06 Range $23.11 - $36.60
Q1 2024
Shares 8,020,136 Value ($000) $227,692 Avg Close $22.62 Range $12.33 - $30.27
Q4 2023
Shares 9,885,449 Value ($000) $131,476 Avg Close $9.77 Range $6.40 - $13.88
Q3 2023
Shares 9,885,449 Value ($000) $88,574 Avg Close $10.77 Range $8.35 - $12.68
Q2 2023
Shares 9,885,449 Value ($000) $111,211 Avg Close $11.80 Range $8.04 - $15.02
Q1 2023
Shares 9,885,449 Value ($000) $113,880 Avg Close $12.99 Range $10.71 - $15.60
Q4 2022
Shares 9,869,483 Value ($000) $114,387 Avg Close $11.57 Range $9.06 - $14.55
Q3 2022
Shares 8,934,902 Value ($000) $113,473 Avg Close $11.47 Range $6.76 - $15.63
Q2 2022
Shares 8,934,902 Value ($000) $61,383 Avg Close $6.89 Range $4.30 - $11.21
Q1 2022
Shares 8,934,902 Value ($000) $86,132 Avg Close $8.51 Range $6.39 - $12.66
Q4 2021
Shares 8,934,902 Value ($000) $106,236 Avg Close $14.05 Range $11.56 - $16.48